Abstract-Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is an important tool for detecting subtle kinetic changes in cancerous tissue. Quantitative analysis of DCE-MRI typically involves the convolution of an arterial input function (AIF) with a nonlinear pharmacokinetic model of the contrast agent concentration. Parameters of the kinetic model are biologically meaningful, but the optimization of the nonlinear model has significant computational issues. In practice, convergence of the optimization algorithm is not guaranteed and the accuracy of the model fitting may be compromised. To overcome these problems, this paper proposes a semi-parametric penalized spline smoothing approach, where the AIF is convolved with a set of B-splines to produce a design matrix using locally adaptive smoothing parameters based on Bayesian penalized spline models (P-splines). It has been shown that kinetic parameter estimation can be obtained from the resulting deconvolved response function, which also includes the onset of contrast enhancement. Detailed validation of the method, both with simulated and in vivo data, is provided.
proton density weighted MRI after calibration or using multiple flip angle sequences [3] , [4] . With Gd-DTPA, the agent does not enter into cells, so DCE-MRI only depicts exchange between the vascular space and the extra-vascular extra-cellular space (EES).
Current approaches to quantitative analysis of DCE-MRI generally rely on nonlinear pharmacokinetic models. These models are usually derived from the solution to a system of linear differential equations, which describe the blood flow in the tissue [5] . In practice, single-compartment models may not always be suitable, and thus more complex models have been suggested. They include the "extended" Tofts-Kermode model and the tissue homogeneity approach [6] , [7] . However, nonlinear regression models are difficult to optimize and the parameter estimation depends on the initial values of the algorithm [6] . As an alternative, Bayesian inference has also been investigated to replace traditional least-square fitting algorithms in MRI [8] , [9] . Bayesian methods allow a more accurate description of the estimation uncertainty and can effectively reduce bias [10] . Furthermore, Bayesian hierarchical models can incorporate contextual information in order to reduce estimation errors [11] .
Recently, model-free techniques have received extensive attention in quantitative imaging. Neural networks are used for tissue classification [12] , [13] and semi-parametric methods have been used for the kinetic modeling of dynamic PET imaging [14] , [15] . For the quantification of first-pass myocardial perfusion, Jerosch-Herold et al. [16] proposed a model-free approach. The formulation of the response function based on a B-spline polynomial representation, however, is ill-conditioned and a first-order difference penalty spline (Tikhonov regularization) has been imposed. A popular, general approach for semi-parametric modeling is based on Penalty splines, or P-splines [17] , [18] . The function under consideration is approximated by a linear combination of a relatively large number of B-spline basis functions. A penalty based on th order differences of the parameter vector ensures the smoothness of the function. For selecting the penalty weight (or smoothing parameter), the L-curve method [19] or cross validation can be used. In Bayesian frameworks, P-splines regression parameters can be estimated jointly with the penalty weight and hence allow for adaptive smoothing [20] , [21] . Due to the rapid changes in DCE-MRI time curves, this is an important requirement for fitting the concentration curves.
In this paper, we propose a Bayesian P-spline model to fit the observed contrast agent concentration time curves. The model uses a locally adaptive smoothing approach as the observed time series signal varies rapidly shortly after injecting the contrast bolus. The proposed algorithm provides a deconvolution approach based on P-splines and results in a smooth response function, along with the corresponding estimates of uncertainty. Kinetic parameters are robustly derived by fitting a nonlinear model to the estimated response function. Here, the proposed algorithm serves as combined denoising and deconvolution technique, which makes the parameter estimation more robust. In addition, the exact onset of the contrast uptake can be determined by using information derived from the Bayesian estimation process. Detailed validation of the method both with simulated and in vivo data of patients with breast tumors is provided.
II. THEORY AND METHODS

A. Standard Kinetic Models for DCE-MRI
The standard parametric model for analyzing contrast agent concentration time curves (CTCs) in DCE-MRI is a single-compartmental model [22] , where the solution can be expressed as a convolution of the arterial input function (AIF) with a single exponential function [23] , i.e.,
Here, denotes the concentration of the contrast agent, denotes the AIF, represents the volume transfer constant between blood plasma and EES, and represents the rate constant between EES and blood plasma. In this study, a more elaborate model based on the adiabatic approximation of tissue homogeneity (AATH) [7] is used. A more general expression of (1) can therefore be written as (2) where is a response function in the tissue. For the AATH model, the response function is defined via for for for ,
where is the transit time through the capillary, is the volume fraction of EES, is the extraction fraction, and is the mean plasma flow. The arterial input function describes the input of the contrast agent into the tissue. DCE-MRI studies typically use a standardized AIF as sampling intervals are too broad to derive a good estimation of the AIF. Throughout this paper we will use a double exponential AIF as proposed by [24] (4) with values , , , and [25] . In (4) , is the actual dosage of tracer in mmol/kg. With this explicit form of the AIF, the convolution of (4) with (3) can be derived analytically.
The kinetic parameters , , and are estimated by fitting the convolved function to the observed data. In addition, the onset time has to be estimated; i.e., the time at which the contrast agent enters into the tissue. Optimization is performed using the Levenberg-Marquardt method [26] , with a grid search algorithm similar to that of [27] . More specifically, a search grid for between 0 and 60 s with , and a search grid for between 30 and 90 s with are used. Parameters , , and are estimated using the minpack.lm R package [28] and the parameter set with the lowest sum of squared residuals (SSR) is chosen. After estimation of for each voxel, the mean is computed for the region of interest (ROI) and the grid search algorithm is repeated to estimate , , , and .
B. Bayesian P-Spline Model for DCE-MRI
Parametric models, however, may not give an accurate fit of the observed data, as they are too simplistic and may overlook effects such as flow heterogeneity or the water exchange effect [29] , [30] . It has been found that semi-parametric models can fit the data more accurately and in this study penalty splines (P-splines) are used in a Bayesian hierarchical framework.
1) Discrete Deconvolution: Assuming that and are constant over small intervals , a discretized form of (2) is given via (5) where is measured on discrete time points , with the number of scans in the dynamic series and the number of time points at which the AIF is evaluated. The matrix may be interpreted as a convolution operator and is defined by if otherwise (6) where is the maximum index for which holds. It is worth noting that the input function is measured-or evaluated from (4)-at time points , which can be different from . However, throughout this paper we use the same time resolution for the AIF and the CTCs, i.e., . 2) Penalty Splines: By solving (5), the response function can be deconvolved from . However, this system may be numerically unstable, i.e., the deconvolved response function can be susceptible to noise. To overcome this problem, we assume that is a smooth, -times differentiable function (we use throughout this study). To this end, a B-spline representation of the response function can be expressed by (7) where with is the design matrix of th order B-splines with knots . In vector notation and (7) may be expressed as . Accordingly, (5) can be written as (8) where is a design matrix, representing the (discrete) convolution of the AIF with the B-spline polynomials.
To enhance the numerical stability, a penalty on the B-spline regression parameters is introduced, such that (9) These models are known as penalty splines or P-splines [17] , [18] as they penalize the roughness of the function , and therefore act as a denoising method. As exhibits a sharp initial increase followed by a sharp decrease at the beginning of the dynamic series, the penalty has to be locally adaptive. That is, the smoothing parameter for the spline is allowed to change over time. The spline can therefore be rough in the initial upslope, and smooth during the washout. A Bayesian hierarchical framework is used for parameter inference.
3) Bayesian Hierarchical Framework: In Bayesian inference, a priori information, i.e., information available before observation, has to be expressed in terms of probability distributions. In this paper, we assume that the observed contrast agent concentration is noisy realization of the true model [ (8)], i.e., (10) where denotes the th row of . That is, a priori the error is assumed to be Gaussian distributed with unknown variance . We use a relatively uninformative prior for the variance parameter, i.e., (11) where denotes the Inverse Gamma distribution, with and . The penalty in (9) can be expressed as an a priori distribution on [21] ( 12) where is the variance of . For a locally adaptive estimation of , the following prior model is used (13) with which allows time varying smoothness penalties. The hyper parameters , , and have been chosen according to existing literature [21] and a sensitivity analysis. The priors are, however, quite uninformative, and small changes to the hyper parameters will not change the performance of the proposed algorithm.
4) Evaluation of the Posterior Distribution:
Bayes' theorem is used to calculate the posterior distribution of the parameter vector which is, up to a normalizing constant, given by (14) A closed-form solution to (14) is however not possible. Markov chain Monte Carlo (MCMC) techniques are therefore used to assess the posterior distribution [31] . The full conditional of , i.e., the joint distribution of given all other parameters and the data, is a -dimensional multivariate normal distribution (15) where is the inverse covariance matrix of the prior distribution of [21] . The full conditionals of both variance parameters are independent Inverse Gamma distributions (16) (17) To assess the posterior distribution, samples of the parameters and are drawn alternately from (15) to (17) . After a sufficient burn-in period, the MCMC algorithm produces samples from the posterior distribution. In this study we use a sample size of 500 to gain reliable error estimates. The MCMC algorithm used a total of 1000 iteration and the first 500 iterations were considered as burn-in.
C. Estimating Kinetic Parameters From the Bayesian P-Spline Model
The advantage of parametric models defined by (1) and (3) is that they contain biologically meaningful and interpretable parameters. The P-spline model only provides a fit to the CTC and a deconvolved and denoised response function, but not kinetic parameters. In this section, we introduce methods for estimating kinetic parameters and the onset of the contrast uptake from the estimated response function. We make use of the fact that the Bayesian approach provides a rich source of information via the posterior distribution of the response function.
1) Determining the Onset of Contrast Uptake:
In practice, the time delay between the injection of the contrast agent and the arrival of the tracer in the tissue of interest is unknown. However, it is important to correctly estimate the delay for a robust estimation of the kinetic parameters [32] . The Bayesian approach yields information on the uncertainty for each parameter in the model and for all transformations of the parameters such as the estimated contrast agent concentration . This results in a point-wise credible interval (CI) for the contrast agent concentration. From this, we can compute the minimal time , where the 99% CI does not cover 0, i.e., at time we are 99% confident that the contrast agent has already entered the tissue.
Assuming that the initial slope of the CTC is approximately linear, we can compute the onset time by drawing a line from to 0 with the gradient . The first order derivative of may be computed via Since is a spline, the derivative may also be computed [33] where is the design matrix of -th order B-splines and is given by In this paper, we propose the following algorithm to estimate the onset of the contrast uptake:
1) find the minimum time , for which the contrast concentration significantly exceeds zero;
2) compute the gradient of the estimated CTC at ;
3) calculate the enhancement onset time as .
DCE-MRI studies typically assume that the onset of the enhancement is the same over the whole region of interest (ROI). In this case, the median of the estimated for all voxels in the ROI may be used as an estimate of the global value. However, for larger ROIs, local estimates of the onset may be required, and are readily available from the proposed technique.
2) Obtaining Kinetic Parameters: The Bayesian P-spline technique provides a posterior distribution of deconvolved and denoised response function. In order to obtain a sample of the posterior distribution of kinetic parameters, one fits a nonlinear function to each sample of the estimated response. That is, we fit the analytical response function of the AATH model as stated in (3) to each estimated response function in the sample. After the onset time of the ROI is determined using the algorithm in Section II-CI, estimation of , , , and is done using the minpack.lm R package. The median of the posterior distribution may be used to estimate the kinetic parameters. Estimation errors can be computed using the standard errors across the samples and credible intervals (CI) can be constructed from quantiles of the posterior distributions.
D. Data Collection 1) Simulated Data Set:
Simulated DCE-MRI data of CTCs with known kinetic parameters were previously published in [6] . We use the first series which was designed to represent data acquired from a breast tumor. Data was simulated using MMID4, part of a software made available by the National Simulation Resource, Department of Bioengineering, University of Washington. Estimates from the literature were used as baseline values following the suggestions of [6] . Flow was modeled through 20 parallel pathways according to a right-skewed lagged normal distribution. Tissue density was set to 1 g/ml, and the volume fraction of the EES, , was fixed at 0.45. We assumed no delay or dispersion of the AIF. For twelve further experiments, one of the kinetic parameters, the mean plasma flow , the capillary plasma volume and the capillary permeability-surface area product was varied four times while the other two were held fixed at the baseline values, according to Table I. 1 http://nsr.bioeng.washington.edu.
Each of the 13 parameter sets was simulated ten times, yielding a dataset of 130 simulated voxels. A time lag of 32 s was added to the simulated data, i.e., zeros were added before the time series. To evaluate the impact of time lag on the proposed algorithm, an additional 32 data sets were simulated with time lags between 33 and 64 s. After simulation, white noise with variance was added to the time curves. To evaluate the impact of observational error on the proposed technique, additional data sets were produced without noise and with variance and , respectively. All data were simulated at 1 Hz, and then down-sampled to 1/8 Hz, to make the experiments more realistic for DCE-MRI data.
2) In vivo Data Set: In vivo data was derived from twelve patients with primary breast cancer (median age 46 years; range 29-70). Each patient was scanned twice, once before and once after two cycles of chemotherapy. Scans were performed with a 1.5 T Siemens MAGNETOM Symphony scanner ( and ) . A dose of body weight Gd-DTPA was injected at the end of the fourth acquisition using a power injector with 4 ml/s with a 20 ml saline flush also at 4 ml/s . This study was provided by the Paul Strickland Scanner Centre at Mount Vernon Hospital, Northwood, U.K. Data from this study was acquired in accordance with the recommendation given by Leach et al. [34] and previously reported [9] , [35] . Informed consent was obtained from all patients. Tumor ROIs were drawn by an expert radiologist based on the dynamic images. The field-of-view for all scans was 260 260 8 mm per slice, with an image resolution of 256 256 for all three slices. An additional slice was placed in the contralateral breast as control, which was not used in this analysis.
For computation of the Gadolinium concentration, signal intensities were converted into relaxation time values using -weighted and proton density weighted images, and data from calibration phantoms with known relaxation times [36] . Baseline values were determined from the average of the first four scans, i.e., before contrast [37] , [38] . The Gadolinium concentration was then computed via , with the longitudinal relaxivity of Gd-DTPA [39] .
III. RESULTS
To validate the proposed methods, we evaluated the fit of the Bayesian P-splines technique of simulated data in comparison to the parametric AATH model. We explore the algorithm for the estimation of onset of the enhancement and the kinetic parameters when the arrival of tracer in the tissue ROI is lagged, and the impact of different levels of observation error. For the simulated data, we used 50 equally distributed knots between and 5.34 min. For in vivo validation, clinical data of 24 DCE-MRI scans of breast cancer patients were analyzed. A series of dynamic images from one of the scans is depicted in Fig. 1 . For this data set, we used a total of 46 knots, 22 of those equally distributed between and 2 min, and 24 equally distributed between 2 and 12 min. For computational reasons, we used less knots after 2 min, as we can assume a smooth washout period at this time.
A. Simulation Studies 1) Evaluation of Fit to Simulated Data:
The P-spline technique provided an accurate fit to the observed contrast agent concentration time curve. For the simulated data, the sum of the squared residuals (SSR) over the whole time series had a range of to with a mean of over all the 130 simulated voxels. With the reference AATH model, the SSR had a range of 0.073-1.825 with a mean of 0.403, i.e., the fit to the observed data was poor in the reference AATH model compared to the proposed Bayesian P-spline technique. Computed for the first minute after the onset of the contrast, the SSR for the P-spline technique had a range of to with a mean of , the SSR for the AATH model had a range of to 0.679 with a mean of 0.197. Fig. 2 depicts the kinetic parameter estimates for the P-spline technique and the reference AATH model compared to the ground truth. Fig. 2(a) shows that the parameter is overestimated with the AATH model-on average by 28.1%. In contrast, estimates with the P-spline technique are much closer to the ground truth. The mean deviation from the ground truth is 6.2%. With the proposed Bayesian P-spline technique, the parameters and are also estimated accurately, but on average is slightly overestimated up to 6.2% compared to a strong overestimation of 39%-100% with the AATH model. For most experiments, the parameter obtained from the P-spline technique is much closer to the ground truth than that of the reference model. For comparison, we also analyzed a simulated data set without noise. Consistent with previously reported results [6] , is slightly overestimated, by up to 12.7% with the AATH model and by up to 11.4% with the Bayesian P-spline technique. The parameter is estimated accurately in most cases with both methods, but a slightly higher standard deviation from the ground truth with the Bayesian P-splines (0.145 versus 0.051). The vascular volume fraction is underestimated by both methods, on average by 56% with the AATH model and 26% by the Bayesian P-spline technique.
An important advantage of the proposed Bayesian technique is that it not only produces point estimates, but also estimations of the errors or interval estimators. Fig. 3 gives 95% credible intervals (CI) for for 13 simulated voxels, representing the 13 parameter sets. For experiment 6, where has small values, the 95% CI is broad but still covers the true value. Overall in 96.2% of the simulated voxels, the 95% CI covered the true value. Similar CI are available for the other kinetic parameters. The Bayesian technique provides important information about both the accuracy and precision of its estimates.
2) Effect of Lag in Enhancement Onset Time:
To validate the proposed algorithm for estimating the onset of the contrast uptake, a time lag of up to 30 s was added to the down-sampled simulation data. Data was analyzed with the proposed P-spline technique and the enhancement onset time and the kinetic parameters were derived by equations described in Section II-C. The estimation of with the proposed method is shown to be accurate. Correlation between the estimated onset time and ground truth was 0.9984. The mean difference between the true and estimated onset time was 0.1800 s with a standard deviation of 0.9339 s and a maximum absolute difference of 2.2992 s. the lagged data was further analyzed without estimation. For a small time lag up to 8 s, i.e., up to one sampling interval, a lag of the onset time has negligible influence on estimation. However, for larger onset lags MAD increases significantly when the onset time is not taken into account.
3) Impact of Different Levels of Observation Error:
To evaluate the impact of noise on the model, we compared simulated data with three different level of observation error. For this purpose, we added white noise with variance to the simulated data. Fig. 5 shows a smoothed histogram of the difference between the 130 estimated and the ground truth values. For the noise level , the difference is nicely distributed around zero with low deviation, but with a small peak at 0.2 due to the overestimation in experiments with low (see Fig. 2 ). In the data with noise level , the distribution of the estimation error is slightly wider. For the highest level of noise, estimation is somewhat biased, mainly due to incorrect estimation of enhancement onset time . However, even at this level of observation error the proposed Bayesian P-spline model is shown to be robust.
B. In Vivo Validation
For each voxel of the 24 scans, the SSR over the whole time series and for the first minute after estimated onset (SSR1), i.e., for the first five time points after onset enhancement as estimated by the respective algorithm, were computed. The median SSR over all voxels with the P-spline technique had a range of 0.0068-0.1830 with a mean of 0.0337. With the AATH model, the SSR had a range of 0.0137-0.1941 with a mean of 0.1371. The SSR1 with the P-spline technique had a range of 0.0023-0.0380 with a mean of 0.0077, the SSR1 with the AATH model had a range of 0.0025-0.0584 with a mean of 0.0315. That is, both the whole time series and the important upslope are better with the P-spline technique. Fig. 6 depicts the observed contrast concentration time series for three voxels from three different scans together with the estimates from the reference AATH model and those from the proposed Bayesian P-spline approach with 95% CI. It is evident that in all voxels the P-spline model fits the data better than the AATH model. The figures also indicate that the AATH model is not always appropriate for the observed data, where the initial upslope is difficult to follow by using the AATH model. In this study, the 95% CI of the contrast agent concentration time series nicely covers the observed CTC. About half the observed points, however, lie outside the CI. The estimated observation error is larger than the estimated error of the CTC, i.e., the uncertainty of the model about the true CTC. Typically, the CI is wider after the upslope of the CTC, and narrow during washout. It widens again at the end of the time series, because the spline fit at the end point relies on fewer observations. Fig. 6 also depicts the median of the estimated deconvolved response function and the fit to the AATH model [(3)] for the same three voxels. Although there is no restriction on the form of the response function, the estimated response always has the expected shape: start at zero, rapid upslope, a short plateau and a nearly exponential downslope. The response function is reasonably well characterized by using (3), and gives robust estimates of the kinetic parameters across the given ROI. However, the first part of the response function is typically slightly underestimated whilst the second part being slightly overestimated. A more flexible parametric model might fit the response function better. Fig. 7 provides the estimated enhancement onset time for all scans; the scanning protocol indicates that the contrast agent was injected at the end of the fourth acquisition (37.05 s). For most scans, the estimated onset time for both models is approximately at the start of the fifth acquisition, which is reasonable given the scanning protocol. For three scans, however, the proposed algorithm based on Bayesian P-splines yields a much larger enhancement onset time, where the search algorithm for the AATH model underestimates the onset time for this scans. For three subjects, the onset times are also displayed in Fig. 6 as vertical dashed line. Visual inspection of this figure and of the other subjects shows that the onset time estimated by the proposed algorithm based on Bayesian P-splines is consistent with the observed contrast concentration time series. Fig. 8 (row 1 and 2 ) depicts the sum of squared residuals (SSR) in the ROI for the Bayesian P-spline technique and the reference AATH model method for the pretreatment scans of three patients. SSRs are clearly reduced over the whole area of the tumor, especially in areas with high values. Therefore, estimates are clearly different for both methods, parameter maps are shown in Fig. 8 (row 3 and 4) . There is, however, no general trend for under-or overestimation between the different methods. For example, for subject 9 the estimates are higher with the AATH model. On the other hand, for patient estimates are too low on average using the AATH model. The strong trend of reduction between pretreatment and posttreatment scans in this study is found by both techniques.
The Bayesian algorithm not only yields point estimates, but also information about the uncertainty of the estimates. Fig. 8 (row 5) depicts the uncertainty in estimation, i.e., the standard deviation of the posterior distribution. Estimation errors are higher with larger values, but they are generally relatively small. For most voxels, the relative error, i.e., standard error divided by estimated parameter, does not exceed 20%.
IV. CONCLUSION
In this paper, we have introduced a semi-parametric technique based on Bayesian P-spline models for quantifying contrast agent concentration time series obtained with DCE-MRI. Compared to parametric models, the proposed Bayesian P-spline technique provides a superior fit to the observed concentration time curves. In particular, the proposed P-spline model captures the upslope of the time series accurately, which is important for an accurate fit of the CTCs in DCE-MRI and proper calculation of .
Results from the simulated data show a clear improvement in both model fit and parameter estimation. In addition, the Bayesian method provides information about the precision, including standard errors or credible intervals. The AATH model could not fit either simulated or in vivo data properly and resulting kinetic parameters were not superior to results from an analysis with the simpler extended Kety model with three free parameters (not shown). This is due to the low time resolution of 8.0 s per scan for the simulated data and 11.9 s per scan for the in vivo data in our study. Previous studies which successfully adapted the AATH model for DCE-MRI [6] , [27] had data with much higher time resolution of 1.0 and 1.5 s per scan, respectively. The P-spline technique allows to fit the AATH response function to the deconvolved and denoised response function despite the low time resolution. For in vivo validation, estimates of kinetic parameters for both techniques are different where the fit of the parametric technique is poor, suggesting that the estimation of kinetic parameters with the proposed Bayesian P-spline technique is more accurate in these areas. The exact assessment of the kinetics is clinically important as changes in respect to the response function and the kinetic parameters can be subtle, especially for drugs that induce multiple effects on tumor vasculature, such as combinations of antiangiogenic drugs [40] .
Nonlinear parametric models are typically difficult to estimate due to convergence issues and problems in specifying consistent starting values. The proposed Bayesian P-spline method provides a reliable and practical way of circumventing these problems. With the proposed technique, computation only includes sampling from standard distributions (see Section II-B4) which can be done efficiently [41] and gives good mixing of the MCMC kernel. In the simulation study, the MCMC algorithm took about 0.877 s per voxel, with an additional 0.019 s per voxel per iteration for the estimation of kinetic parameters including the posterior distribution. That is, per voxel the P-spline-based algorithm took about 10.38 s. For comparison, the search grid algorithm for the AATH model, as described in Section II-A, took about 31.56 s per voxel. In contrast to classical approaches [16] , Bayesian P-splines allow simultaneous estimation of model and smoothing parameters. Adaptive smoothing parameters can be obtained and are important to model the sharp changes in the dynamic series of the contrast concentration.
One unique feature of the paper is the estimation of the onset of the CTC based on Bayesian inference. Onset time can be determined for the whole region of interest or on a more local level. It is an important parameter in quantitative DCE-MRI models as it has great influence on other parameters in the kinetic model and an incorrect onset time can lead to a strong bias in parameter estimates [10] . Onset time is also an important clinical index for characterizing suspicious breast lesions [42] , although in this study they are not evident across patients.
The proposed technique also intrinsicly allows for quantification of estimation errors both in fitting the observed data and in estimating kinetic parameters. The Bayesian framework has been proposed previously for the assessment of estimation error [10] , [11] . Alternative methods for assessing the estimation error include bootstrapping [43] , error propagation [44] and nonlinear regression asymptotics [9] . This study does not investigate other possible sources of error; e.g., the computation of tracer concentration or the choice of the AIF. The quantification of error in estimation of kinetic parameters in the proposed technique can contribute to the evaluation of the quality of DCE-MRI scans. Results from the Bayesian P-spline technique can therefore serve as a supporting tool for quality control. When choosing a pixel, the CTC would be displayed interactively along with the P-spline fit, the CI, and the estimated onset time. This would not only help to assess the quality of the data, but also make it easier to understand what is actually happening physiologically.
The proposed method allows a direct assessment of the response function, i.e., the actual flow in the tissue. Parameters of interest may be estimated by fitting a nonlinear model to the response function. Smoothing via P-splines provides an effective way of error reduction and deconvolution of the arterial input function.
